Innovative thinking and finesse with robotic and minimally invasive surgical techniques are benefiting patients in the local region as well as across the globe.
Urologic surgeons from the UC College of Medicine and UC Health recently shared their expertise in minimally invasive prostate and kidney cancer at the First International Meeting on Minimally Invasive Surgery in Urologic Oncology, held at the Institute of Urology at the Ministry of Health Care and Social Development of the Russian Federation in Moscow.
They were one of two U.S.-based urology teams to present at the international meeting, held March 24 and 25, 2011. Urologists from across Europe, Russia and the United States attended the conference, which explored topics ranging from the balance between maintaining a patient’s quality of life and tumor control to theoretical discussions of decisions in treatment strategy.
About 100 urologists attended the meeting in Moscow, with hundreds more watching a live webcast throughout Russia. James Donovan, MD, chief of UC’s division of urology, spoke about modern methodology and new technologies in prostate biopsy.
Vladimir Mouraviev, MD, UC urology endo-urology fellow, presented on cryoablation of prostate cancer and focal therapy, a newer approach to treating early stage prostate cancer that involves advances in imaging of prostate cancer and selectively freezing cancerous tissue to destroy the malignant cells, while avoiding radical prostatectomy or radiation therapy and their associated drawbacks.
Krishnanath Gaitonde, MD, discussed the benefits of partial nephrectomy in cases of kidney cancer as well as the use of robot-assisted techniques in select patients.
"Cyroablation is becoming a more widely accepted treatment for non-metastatic prostate cancer and small renal tumors. We’re excited to offer it as an option for patients in Greater Cincinnati,” says Donovan.
While in Russia, Donovan, Mouraviev and Gaitonde also performed two surgical cases: A 53-year-old man with localized prostate cancer who underwent cryosurgery; and a 31-year-old woman with a benign kidney tumor.
Both cases served as demonstrations of robotic and minimally invasive urologic techniques for surgeons attending the conference.
Recent Innovations in UC Urology:
UC Health’s urologists are pushing the envelope in providing innovative, minimally invasive treatments for patients with prostate and kidney cancers.
Recently, Nilesh Patil, MD, introduced a catheter-less robotic prostatectomy. In traditional surgery, patients have a penile catheter for seven to 10 days post-op to drain urine while the surgical site heals.
The new technique involves draining urine directly from the bladder through a small incision and tube inserted just above the pubic bone. This allows the patient to begin draining urine faster post-op, and spares the patient the discomfort of a catheter.
Donovan, Gaitonde and Mouraviev—in collaboration with Glenn Taylor, MD, a private practice radiologist at West Chester Hospital—have launched a program for computed tomography (CT)-guided percutaneous cryoablation procedures for small renal tumors.
The procedure targets kidney tumors located posteriorly which are accessible under CT guidance allowing biopsy and destruction by cryoablation.
The procedure involves using CT imaging technology to guide a small needle through the skin and into the kidney to freeze cancerous tissue.
Typically, patients are discharged the day after surgery, with return to regular activity in two weeks. The UC division of urology and department of radiology will introduce focal therapy for prostate cancer to the region in the coming months.